Malta - English - Medicines Authority

astrazeneca uk limited 600, capability green, luton lu1 3lu, united kingdom - zafirlukast - tablet - zafirlukast 20 mg - drugs for obstructive airway diseases

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - zafirlukast - oral tablet - 20mg

Canada - English - Health Canada

astrazeneca canada inc - zafirlukast - tablet - 20mg - zafirlukast 20mg - leukotriene modifiers

United States - English - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - zafirlukast - coated tablets - 20 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - zafirlukast - coated tablets - 40 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - zafirlukast - film coated tablet - 20 milligram - leukotriene receptor antagonists

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - zafirlukast - oral tablet - 20mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - zafirlukast - oral tablet - 20mg